Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Azzi, R. Fanci, S. Ciappi, K. Zakrzewska, A. Bosi (1993)
Human parvovirus B19 infection in bone marrow transplantation patientsAmerican Journal of Hematology, 44
(2001)
medicine . Summary of a workshop
P. Mortimer, N. Luban, J. Kelleher, B. Cohen (1983)
TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATESThe Lancet, 322
Young Young, Brown Brown (2004)
Parvovirus B19N Engl J Med, 350
H. Niitsu, H. Takatsu, I. Miura, A. Chubachi, T. Ito, M. Hirokawa, Y. Endo, A. Miura, M. Fukuda, T. Sasaki (1990)
[Pure red cell aplasia induced by B19 parvovirus during allogeneic bone marrow transplantation].[Rinsho ketsueki] The Japanese journal of clinical hematology, 31 9
M. Itälä, P. Kotilainen, S. Nikkari, K. Remes, J. Nikoskelainen (1997)
Pure red cell aplasia caused by B19 parvovirus infection after autologous blood stem cell transplantation in a patient with chronic lymphocytic leukemiaLeukemia, 11
A. Zanella, F. Rossi, C. Cesana, A. Foresti, F. Nador, A. Binda, G. Lunghi, M. Cappellini, M. Furione, G. Sirchia (1995)
Transfusion‐transmitted human parvovirus B19 infection in a thalassemic patientTransfusion, 35
F. Hayakawa, K. Imada, M. Towatari, H. Saito (2002)
Life‐threatening human parvovirus B19 infection transmitted by intravenous immune globulinBritish Journal of Haematology, 118
J. Abkowitz, K. Brown, R. Wood, N. Kovach, S. Green, N. Young (1997)
Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection.The Journal of infectious diseases, 176 1
C. Sosa, J. Mahony, K. Luinstra, M. Sternbach, M. Chernesky (1992)
Replication and cytopathaology of human parvovirus B19 in human umbilical cord blood erythroid progenitor cellsJournal of Medical Virology, 36
B. Hayes-Lattin, Timothy Seipel, K. Gatter, M. Heinrich, R. Maziarz (2004)
Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantationAmerican Journal of Hematology, 75
K. Brown, N. Young, B. Alving, L. Barbosa (2001)
Parvovirus B19: implications for transfusion medicine. Summary of a workshopTransfusion, 41
Parvovirus B 19 : implications for
E. Heegaard, Bodil Petersen (2000)
Parvovirus B19 transmitted by bone marrowBritish Journal of Haematology, 111
S. Modrow, S. Dorsch (2002)
Antibody responses in parvovirus B19 infected patients.Pathologie-biologie, 50 5
(1992)
Replication and cytopathology of human parvovirus B19 in human umbilical cord blood erythroid progenitor cells
R. Cavallo, C. Merlino, D. Re, C. Bollero, M. Bergallo, David Lembo, Tiziana Musso, G. Leonardi, G. Segoloni, A. Ponzi (2003)
B19 virus infection in renal transplant recipients.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 26 3
S. Kobayashi, A. Maruta, T. Yamamoto, N. Katayama, Russell Higuchi, Y. Sakano, H. Fujita, H. Koharazawa, N. Tomita, J. Taguchi, F. Kodama, Y. Nakamura, A. Shimizu (1999)
Human Parvovirus B19 Capsid Antigen in Granulocytes in Parvovirus-B19-Induced Pancytopenia after Bone Marrow TransplantationActa Haematologica, 100
M. Shipp, D. Harrington, James Anderson, J. Armitage, G. Bonadonna, G. Brittinger, F. Cabanillas, G. Canellos, B. Coiffier, J. Connors, R. Cowan, D. Crowther, S. Dahlberg, M. Engelhard, R. Fisher, C. Gisselbrecht, S. Horning, É. Lepage, T. Lister, J. Meerwaldt, E. Montserrat, N. Nissen, M. Oken, B. Peterson, C. Tondini, W. Velasquez, B. Yeap (1993)
A predictive model for aggressive non-Hodgkin's lymphoma.The New England journal of medicine, 329 14
T. Pumarola (1995)
[Parvovirus B19].Medicina clinica, 104 1
P. Carbone, H. Kaplan, K. Musshoff, D. Smithers, M. Tubiana (1971)
Report of the Committee on Hodgkin's Disease Staging Classification.Cancer research, 31 11
B. Serjeant, I. Hambleton, S. Kerr, C. Kilty, G. Serjeant (2001)
Haematological response to parvovirus B19 infection in homozygous sickle-cell diseaseThe Lancet, 358
(1996)
stem cell transplantation after B 19 parvovirus infection
M. Oken, R. Creech, D. Tormey, J. Horton, T. Davis, E. McFadden, P. Carbone (1982)
Toxicity and response criteria of the Eastern Cooperative Oncology GroupAMERICAN JOURNAL OF CLINICAL ONCOLOGY, 5
Application of nucleic acid testing to blood borne pathogens and emerging technologies. OBRR/CBER/ FDA workshop
C. Prowse, C. Ludlam, P. Yap (1997)
Human Parvovirus B19 and Blood ProductsVox Sanguinis, 72
(1997)
Pure red cell aplasia caused by B 19 parvovirus infection after autologous blood stem cell transplantation in a patient with chronic lymphocytic
N Engl J Med, 329
H. Weiland, M. Salimans, W. Fibbe, P. Kluin, B. Cohen (1989)
PROLONGED PARVOVIRUS B19 INFECTION WITH SEVERE ANAEMIA IN A BONE MARROW TRANSPLANT RECIPIENTBritish Journal of Haematology, 71
E. Tabor, J. Epstein (2002)
NAT screening of blood and plasma donations: evolution of technology and regulatory policy *Transfusion, 42
Application of nucleic acid testing to blood borne pathogens and emerging technologies
A. Gianni, M. Bregni, Salvatore Siena, C. Brambilla, M. Nicola, F. Lombardi, L. Gandola, C. Tarella, A. Pileri, F. Ravagnani, P. Valagussa, G. Bonadonna (1997)
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.The New England journal of medicine, 336 18
M. Koppelman, H. Cuypers, T. Emrich, H. Zaaijer (2004)
Quantitative real‐time detection of parvovirus B19 DNA in plasmaTransfusion, 44
C. Solano, O. Juan, C. Gimeno, J. Garcia-conde (1996)
Engraftment failure associated with peripheral blood stem cell transplantation after B19 parvovirus infection.Blood, 88 4
(1997)
Chronic anemia due to parvovirus B 19 infection in a bone marrow transplant patient after platelet
BJ Cohen, S. Beard, WA Knowles, J. Ellis, D. Joske, J. Goldman, P. Hewitt, K. Ward (1997)
Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusionTransfusion, 37
BACKGROUND: Parvovirus B19 is a cause of delayed red blood cell (RBC) engraftment after marrow transplantation (BMT). The diagnosis of parvovirus infection requires serologic and DNA testing in the context of clinical disease and characteristic marrow morphologic findings; however, the source of infection is often difficult to determine. STUDY DESIGN AND METHODS: Investigation of a case of delayed RBC engraftment and pure RBC aplasia (PRCA) occurring 3 months after autologous peripheral blood progenitor cell (PBPC) transplantation in a patient with high‐risk diffuse large B‐cell lymphoma. DNA testing of serum and of a sample of cryopreserved PBPCs was performed. RESULTS: Marrow morphology showed a maturational arrest of erythroid cells with giant proerythroblasts. Polymerase chain reaction and nucleic acid hybridization confirmed the presence of parvovirus DNA in the serum and in a sample of sequestered PBPCs saved at the time of PBPC harvest. PRCA resolved after the administration of intravenous immune globulin. CONCLUSION: Autologous PBPCs are a potential source of parvovirus infection, which may cause significant disease after autologous BMT.
Transfusion – Wiley
Published: Mar 1, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.